Atara Biotherapeutics

-$0.02 (-0.43%) As of 5:09 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATRA and other ETFs, options, and stocks.

About ATRA

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219.

CEO
Pascal Touchon
Employees
578
Headquarters
South San Francisco, California
Founded
2012

ATRA Key Statistics

Market cap
436.20M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.33M
High today
$4.99
Low today
$4.65
Open price
$4.70
Volume
333.65K
52 Week high
$20.04
52 Week low
$4.61

ATRA News

BenzingaMay 20

Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara

Atara Biotherapeutics Inc (NASDAQ: ATRA) received notification that Bayer AG's (OTC: BAYRY) intends to end the exclusive worldwide licensing agreement for mesot

ATRA Earnings

-$1.09
-$0.73
-$0.36
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure